Host PI3K inhibition via anti-cancer drug alpelisib influences Influenza A non-infectious particles and deletion-containing viral genomes
Ilechukwu Agu, Ivy José, Abhineet Ram, Daniel P Oberbauer, John G Albeck, Samuel L Díaz-Muñoz · 2025
Read Host PI3K inhibition via anti-cancer drug alpelisib influences Influenza A non-infectious particles and deletion-containing viral genomes by Ilechukwu Agu, Ivy José, Abhineet Ram, Daniel P Oberbauer, John G Albeck, Samuel L Díaz-Muñoz (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12751567.txt.
Description
Ilechukwu Agu and co-authors test whether a cancer drug that blocks a host growth pathway can change flu virus output. Their 2025 study starts from a known fact: flu makes many flawed genome copies, and those flawed copies can soften infection. Most past work blamed virus proteins for how many flawed copies form.
The team blocked the host pathway in infected cells and tracked flawed genomes and non-infectious particles. One flu strain sharply raised its flawed copies under the drug, while a second strain did not. The second strain instead made slightly more non-infectious particles. The authors argue that host cell state shapes virus output. Strain gaps point to a virus-host contact worth probing next.
Catalog record
| CREATOR | Ilechukwu Agu, Ivy José, Abhineet Ram, Daniel P Oberbauer, John G Albeck, Samuel L Díaz-Muñoz |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |